Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Launches Tonmya; Commercial Rollout Should Accelerate Near-Term Revenue
![]() |
Commercial availability of Tonmya positions the company to convert clinical success into product revenue while cash reserves extend the operational runway through planned milestones. Technical momentum and high liquidity create a volatile but actionable near-term setup for market participants. |








